This inventor holds 27 USPTO granted patents and 11 published patent applications and 26 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Bayer Pharma Aktiengesellschaft, Bayer Intellectual Property Gmbh, Bayer Aktiengesellschaft. Active years: 2005-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Berlin, DE (2005 - 2009)
- Bergfelde, DE (2013 - 2017)
- OT Bergfelde, DE (2016 - 2017)
- Hohen Neuendorf, DE (2019 - 2020)
- OT Bergf, DE (2016 - 2022)
Company Filing History:
14 out of 386 
8 out of 721 
4 out of 12,266 
Years Active: 2005-2026
Areas of Expertise:
Title: Volker Schulze: Innovator in Pharmaceutical Compounds
Introduction
Volker Schulze, based in OT Bergf, Germany, is a prominent inventor with a remarkable portfolio of 24 patents. His work primarily focuses on innovative pharmaceutical compounds, demonstrating his significant contribution to the field of medicinal chemistry.
Latest Patents
Among Schulze's latest inventions are notable patents involving 3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as CSNK1 inhibitors. This invention describes processes for producing compounds that serve as inhibitors of Casein kinase 1 alpha and/or delta (CSNK1α and/or β), which are essential for the treatment of proliferative disorders. Additionally, he has developed 4H-pyrrolo[3,2-c]pyridin-4-one derivatives, showcasing the versatility and applicability of his inventions in the pharmaceutical industry.
Career Highlights
Schulze's career includes significant roles at Bayer Pharma Aktiengesellschaft and Bayer Intellectual Property GmbH. His tenure at these reputable organizations has allowed him to refine his skills in both research and the intellectual property management of scientific innovations.
Collaborations
Throughout his career, Schulze has worked alongside notable colleagues such as Philip Lienau and Knut Eis. These collaborations have undoubtedly enhanced his research capabilities and broadened the scope of his innovative contributions to the field.
Conclusion
Volker Schulze stands out as a significant figure in the innovation landscape, particularly in the realm of pharmaceuticals. With 24 patents to his name, his work continues to pave the way for advances in medical treatments, showcasing the importance of innovation in addressing complex health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile